Clinical Trials Browser

Zollinger-Ellison Syndrome

NCT02454075 2021-01-29

YF476 and Type II Gastric Carcinoids

Phase 2 Terminated

3 enrolled 11 charts

Zollinger-Ellison Syndrome

NCT00454363 2020-04-03

Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

Phase 2 Completed

52 enrolled 11 charts

Endocrine

Glucagonoma, Insulinoma, Somatostatinoma, Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasia Type 1

NCT02831179 2017-09-28

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Phase 1 Withdrawn

DermatologicEndocrineGastrointestinalNET

Non functioning pancreatic endocrine tumor, Adrenal Cortex Neoplasms, Carcinoid Tumor, Vipoma, Glucagonoma, Insulinoma, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Carcinoma, Merkel Cell, Carcinoma, Medullary, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Multiple Endocrine Neoplasia Type 2b

NCT00001191 2017-07-02

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

Phase 2 Completed

Zollinger-Ellison Syndrome, Gastrinoma

NCT00001228 2017-07-02

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

Phase 2 Completed

50 enrolled

Adenoma, Islet Cell, Zollinger-Ellison Syndrome

NCT00001241 2017-07-02

Treatment of Zollinger-Ellison Syndrome

Completed

Zollinger-Ellison Syndrome

NCT02153398 2017-01-19

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

Phase 3 Completed

55 enrolled 31 charts

Gastrointestinal

Duodenal Ulcer, Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT00869050 2016-07-25

Capecitabine and Temozolomide for Neuroendocrine Cancers

Phase 2 Completed

41 enrolled 9 charts

EndocrineGastrointestinalNET

Carcinoid Tumor, Vipoma, Pancreatic Neoplasms, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors

NCT01204476 2016-07-15

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Phase 1 Completed

27 enrolled

CNSDermatologicEndocrine

Glucagonoma, Insulinoma, Paraganglioma, Somatostatinoma, Zollinger-Ellison Syndrome, Carcinoma, Merkel Cell, Carcinoma, Medullary

NCT01434485 2014-04-16

Nexium Capsules Clinical Experience Investigation

Completed

3,691 enrolled

Gastrointestinal

Non-Erosive Reflux Disease, Duodenal Ulcer, Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT00204373 2012-10-30

Treatment of Zollinger-Ellison Syndrome With Prevacid

Phase 4 Completed

72 enrolled 8 charts

Endocrine

Multiple Endocrine Neoplasia, Zollinger-Ellison Syndrome

NCT00942175 2012-02-03

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Phase 1 Completed

160 enrolled 16 charts

Gastrointestinal

Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT00079833 2010-11-19

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

Phase 3 Completed

25 enrolled

Zollinger-Ellison Syndrome

NCT00001240 2008-03-05

Evaluating Patients With Abnormal Levels of Gastric Acid

Completed

Achlorhydria, Zollinger-Ellison Syndrome, Gastrinoma

NCT00001165 2008-03-04

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

Phase 2 Completed

999 enrolled

Adenoma, Islet Cell, Neoplasm Metastasis, Zollinger-Ellison Syndrome, Gastrinoma

Clinical Trials

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

YF476 and Type II Gastric Carcinoids

Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

Treatment of Zollinger-Ellison Syndrome

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

Capecitabine and Temozolomide for Neuroendocrine Cancers

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Nexium Capsules Clinical Experience Investigation

Treatment of Zollinger-Ellison Syndrome With Prevacid

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

Evaluating Patients With Abnormal Levels of Gastric Acid

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas